HB1004: Public Health - Alzheimer's Disease and Related Dementias - Information on Prevalence and Treatment
Legislative Summary
Requiring the Maryland Department of Health, in partnership with certain entities, to incorporate information regarding treatments approved by the Food and Drug Administration for Alzheimer's disease and related dementias and to increase understanding and awareness of treatment of Alzheimer's disease and related dementias into relevant public health outreach programs; requiring the Department to establish and maintain a website with information on the prevalence and hospitalization rate for Alzheimer's and related dementias; etc.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Amendments
Favorable with Amendments 813125/1 Adopted
Favorable with Amendments 813125/1 Adopted
Roll Call Votes
Status Information
Sponsors
Primary Sponsor
